Medicines and Healthcare Products Regulatory Agency: Finance

(asked on 16th March 2023) - View Source

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, with reference to paragraph 3.100 of the Spring Budget Report 2023, HC1183, published in March 2023, what the evidential basis is for the adequacy of £10 million funding in the MHRA achieving the objective of having a fully operational approval process in place from 2024.


Answered by
John Glen Portrait
John Glen
Paymaster General and Minister for the Cabinet Office
This question was answered on 23rd March 2023

£10m over 2 years represents a significant increase in the funding MHRA receives from government. This funding, along with proposals to make greater use of international recognition, was based on extensive work by the MHRA and detailed discussions with HMT. It will ensure MHRA is able to implement swift new approvals processes from next year.

Reticulating Splines